145 related articles for article (PubMed ID: 2484689)
1. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
Bult H; Fret HR; Herman AG
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
4. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
5. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects.
Bassenge E; Mülsch A
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S23-8. PubMed ID: 2484695
[TBL] [Abstract][Full Text] [Related]
6. [Effect of SIN 1 on the interactions of endothelial cells and thrombocytes].
Kirchmaier CM; Altorjay I; Bellinger O; Breddin HK
Z Kardiol; 1991; 80 Suppl 5():13-6. PubMed ID: 1776329
[TBL] [Abstract][Full Text] [Related]
7. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
10. Effects of SIN-1 on isolated canine basilar arteries.
Katusic ZS; Vanhoutte PM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S72-5. PubMed ID: 2484704
[TBL] [Abstract][Full Text] [Related]
11. Molsidomine is a donor of EDRF.
Vanhoutte PM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S139-40. PubMed ID: 2484694
[No Abstract] [Full Text] [Related]
12. Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.
Karrenbrock B; Heim JM; Gerzer R
Klin Wochenschr; 1990 Feb; 68(4):213-7. PubMed ID: 2156106
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
Lagarde M; Bordet JC; Croset M
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
15. [Interaction between thrombocytes and the coronary system in the presence of SIN 1 and nitroglycerin after endothelial damage].
Rösen R; Bernards W; Jumpertz K; Kreie KJ; Wiesmüller G; Klaus W
Z Kardiol; 1991; 80 Suppl 5():23-7. PubMed ID: 1776331
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
Bassenge E
Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
[TBL] [Abstract][Full Text] [Related]
17. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels.
Lüscher TF; Richard V; Yang ZH
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S76-80. PubMed ID: 2484705
[TBL] [Abstract][Full Text] [Related]
18. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
[TBL] [Abstract][Full Text] [Related]
19. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
20. Isosorbidedinitrate and SIN-1 as dilators of human coronary arteries and platelet inhibitors.
Bult H; Bosmans JM; Vrints CJ; Herman AG
J Cardiovasc Pharmacol; 1995 Apr; 25(4):572-8. PubMed ID: 7596125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
